Synthesis of 4-Aminoquinazolines
FULL PAPER
equal to camptothecin.[11] All of the compounds reported in
Scheme 3 can therefore be considered to be potential topoi-
somerase I inhibitors. In addition, these compounds have
potential as, for example, kinase inhibitors.[7] Therefore, the
constructed library of 4-aminoquinazolines could serve as a
valuable source of new leads in various fields of medicinal
chemistry. Biological activities of compounds 1 will be re-
ported in due course.
[1] For recent reviews of palladium-catalyzed carbonylation reactions,
[2] For examples of transition metal-catalyzed cyclization reactions in-
corporating isocyanides, see: a) M. Zhang, S. L. Buchwald, J. Org.
Conclusion
We have developed an efficient Pd-catalyzed intramolecular
imidoylative cross-coupling reaction of readily available N-
(2-bromoaryl)amidines, yielding 4-aminoquinazolines that
are of considerable interest in medicinal and agricultural
chemistry. We have optimized the reaction with respect to
the ligand, catalyst loading, base, temperature, and solvent.
[3] For a recent review of palladium-catalyzed cascade cyclizations, see:
[4] a) B. Crociani, F. Dibianca, R. Bertani, C. B. Castellani, Inorg.
Schuster, L. Yang, H. G. Raubenheimer, M. Albrecht, Chem. Rev.
P. W. N. M. van Leeuwen, N. Veldman, A. L. Spek, F. J. R. van Neer,
[5] K. S. Masters, T. R. M. Rauws, A. K. Yadav, W. A. Herrebout, B.
[6] For 1H-benzimidazole synthesis involving Pd-catalyzed intramolecu-
68, 6814–6816; c) J. M. Travins, R. C. Bernotas, D. H. Kaufman, E.
Quinet, P. Nambi, I. Feingold, C. Huselton, A. Wilhelmsson, A.
[7] Rho kinase inhibitors: a) P. Sweetnam, A. Bartolozzi, A. Campbell,
B. Cole, H. Foudoulakis, B. Kirk, H. Seshadri, S. Ram (Surfacelogix,
Brighton, MA, USA), WO2010/104851A1, 2010. CHK2 kinase in-
hibitors: b) I. Collins, A. W. Oliver, T. M. Raynham, C. A. J. Matijs-
sen, E. J. Welsh, J. J. Caldwell, (Cancer Research Technology,
London, UK), WO2009/53694A1, 2009; c) J. J. Caldwell, E. J. Welsh,
C. Matijssen, V. E. Anderson, L. Antoni, K. Boxall, F. Urban, A.
Hayes, F. I. Raynaud, L. J. M. Rigoreau, T. Raynham, G. W. Aherne,
L. H. Pearl, A. W. Oliver, M. D. Garrett, I. Collins, J. Med. Chem.
Easier to handle PdACTHNUTRGNEN(UG OAc)2, in comparison with [PdCAHTUNGTNER(NUGN dba)2],
proved to be equally suited as the Pd source and generally
allowed the use of the relatively inexpensive (compared
with XPhos) ligand DCPB. An array of diversely substituted
amidines can be combined with various aliphatic isocyanides
to afford the target 4-aminoquinazolines in good to excel-
lent yield, although fine-tuning of the reaction conditions
was required for the more challenging substrates. The syn-
thesized 4-aminoquinazolines include known potent topoiso-
merase I inhibitors, as well as phosphodiesterase inhibitors.
The high modularity and mild reaction conditions make this
methodology very attractive for future applications in me-
dicinal chemistry.
Experimental Section
General procedure for the synthesis of 4-aminoquinazolines (1) by Pd-
catalyzed intramolecular imidoylation of N-(2-bromoaryl)amidines (3): A
round-bottomed flask was charged with PdACTHNUTRGENUN(G OAc)2 (7 mg, 0.03 mmol) and
DCPB (21 mg, 0.06 mmol), followed by dry DMF (3 mL). The mixture
was flushed with N2 for 10 min. Meanwhile, amidine 3 (1.0 mmol), KOAc
(3.0 mmol, 3 equiv), and isocyanide 2 (1.5 mmol, 1.5 equiv) were added
to another round-bottomed flask. The Pd catalyst solution was then
added to this mixture, and the flask was subsequently flushed with N2 for
5 min. The resulting mixture was heated at the indicated temperature in
a pre-heated oil bath for 7 h under magnetic stirring. After cooling to
room temperature, EtOAc was added and the suspension was filtered
over a pad of Celite and rinsed with EtOAc (125 mL). The solvent was
removed under reduced pressure and the residue was purified by flash
column chromatography on silica gel to afford 4-aminoquinazolines 1 in
high purity.
[8] T. C. Gahman, D. J. Thomas, M. E. Massari, H. Lang (Kalypsis, San
Diego, CA, USA), WO2008/157500A1, 2008.
[9] M. Reich, S. Kuehnert, S. Oberboersch, M. Haurand, K. Schiene
(Gruenenthal, Aachen, DE), US2009/69320A1, 2009.
[10] D. Wilson, L. T. D. Fanning, P. Krenitsky, A. Termin, P. Joshi, U.
Sheth (Vertex Pharmaceuticals Incorporated, Cambridge, MA,
USA), US2008/167305A1, 2008.
[11] T. N. Le, S. H. Yang, D. B. Khadka, H. T. M. Van, S. H. Cho, Y.
[12] These conditions proved to be successful for domino condensation/
Heck cyclization reactions on 3-amino-4-bromoquinoline and 3-
amino-4-bromoisoquinoline with acetaldehyde, see: G. Van Baelen,
G. L. F. Lemiꢃre, R. A. Dommisse, B. U. W. Maes, ARKIVOC 2009,
vi, 174–182.
Acknowledgements
This work was financially supported by the Netherlands Organization for
Scientific Research (NWO) by means of a Rubicon grant to Dr. Gitte
van Baelen and by the Hercules Foundation. We thank Dr. M. T. Smo-
luch (VU University) for (HR)MS measurements.
[13] For a recent review of the use of dialkylbiaryl phosphines in Pd-cat-
Chem. Eur. J. 2011, 17, 15039 – 15044
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
15043